Scientific publications for BioPredictive non-invasive diagnostics

The Association of Histologic and Noninvasive Tests With Adverse Clinical and Patient-Reported Outcomes in Patients With Advanced Fibrosis Due to Nonalcoholic Steatohepatitis.

Younossi ZM et al. · Gastroenterology · 2021 Match 100

### Background & Aim Fibrosis is an independent predictor of death in nonalcoholic steatohepatitis…

FibroTest Metabolic

Hepatotoxicity of tocilizumab and anakinra in rheumatoid arthritis: management decisions.

Mahamid M et al. · Clin Pharmacol · 2011 Match 98

### Background Elevation of liver enzymes in rheumatoid arthritis patients treated with tocilizumab…

FibroTest Other

Sofosbuvir/velpatasvir in patients with hepatitis C virus genotypes 1-6 and compensated cirrhosis or advanced fibrosis.

Asselah T et al. · Liver Int · 2018 Match 96

### Background & Aims Patients with chronic hepatitis C virus infection and advanced fibrosis…

FibroTest HCV

Comparison of fatty liver index with noninvasive methods for steatosis detection and quantification.

Zelber-Sagi S et al. · World J Gastroenterol · 2013 Match 94

### Aim To compare noninvasive methods presently used for steatosis detection and quantification…

SteatoTest Metabolic

Clinical and genetic definition of serum bilirubin levels for the diagnosis of Gilbert syndrome and hypobilirubinemia.

Poynard T et al. · Hepatol Commun · 2023 Match 91

FibroTest Other

Assessment of methotrexate hepatotoxicity in psoriasis patients: a prospective evaluation of four serum fibrosis markers.

Chládek J et al. · J Eur Acad Dermatol Venereol · 2013 Match 89

### Background Low-dose oral methotrexate (MTX) is an effective immunosuppressive therapy for…

FibroTest Other

Efficacy and safety of tenofovir disoproxil fumarate in Asian-Americans with chronic hepatitis B in community settings.

Pan CQ et al. · PLoS One · 2014 Match 87

### Background And Aims Chronic hepatitis B (CHB) disproportionately affects the Asian-American…

FibroTest HBV

A prospective assessment of an 'a la carte' regimen of PEG-interferon alpha2b and ribavirin combination in patients with chronic hepatitis C using biochemical markers.

d'Arondel C et al. · J Viral Hepat · 2006 Match 85

In therapy with standard interferon and ribavirin, five independent risk factors (RF…

ActiTest FibroTest HCV

Real-world efficacy and safety of ombitasvir, paritaprevir/r+dasabuvir+ribavirin in genotype 1b patients with hepatitis C virus cirrhosis.

Preda CM et al. · Liver Int · 2018 Match 82

### Background Direct antiviral agents (DAA) showed very good results in terms of…

FibroTest HCV

Comparison of liver fibrosis blood tests developed for HCV with new specific tests in HIV/HCV co-infection.

Calès P et al. · J Hepatol · 2010 Match 80

### Background & Aims We compared 5 non-specific and 2 specific blood tests…

FibroTest HCV HIV

Hepatitis C in 6,865 patients 65 yr or older: a severe and neglected curable disease?

Thabut D et al. · Am J Gastroenterol · 2006 Match 78

### Background Few data are available on chronic hepatitis C (CHC) in elderly…

FibroTest HCV

Improved inflammatory activity with peginterferon alfa-2b maintenance therapy in non-cirrhotic prior non-responders: a randomized study.

Poynard T et al. · J Hepatol · 2013 Match 75

### Background & Aims Therapeutic options for patients failing hepatitis C retreatment are limited…

ActiTest FibroTest HBV

Management of the patient with SVR. Review

Terrault NA et al. · J Hepatol · 2016 Match 73

In the current era of therapy with direct-acting antiviral (DAAs) drugs…

FibroTest HCV

Guidelines for the Prevention, Care and Treatment of Persons with Chronic Hepatitis B Infection

· 2015 Match 71

These are the first World Health Organization (WHO) guidelines for the prevention…

FibroTest HBV

Performance of serum apolipoprotein-A1 as a sentinel of Covid-19. Key publication

Poynard T et al. · PLoS One · 2020 Match 69

### Background Since 1920, a decrease in serum cholesterol has been identified as…

FibroTest Other

EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease.

European Association for the Study of the Liver (EASL) et al. · Obes Facts · 2016 Match 66

FibroTest SteatoTest Metabolic

Transient Elastography for Assessment of Liver Fibrosis and Steatosis: An Evidence-Based Analysis. Review

Brener S · Ont Health Technol Assess Ser · 2015 Match 64

### Background Liver fibrosis is a sign of advanced liver disease and is…

Elasto-FibroTest FibroTest Alcohol HBV +3

Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus. Key publication

AASLD/IDSA HCV Guidance Panel · Hepatology · 2015 Match 62

ActiTest FibroTest HCV

Guidelines for the Screening, Care and Treatment of Persons with Hepatitis C Infection Key publication

· 2014 Match 60

These are the first guidelines dealing with hepatitis C treatment produced by…

FibroTest HCV

EASL Clinical Practice Guidelines: management of hepatitis C virus infection.

European Association for the Study of the Liver · J Hepatol · 2011 Match 57

ActiTest FibroTest HCV

Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance.

Terrault NA et al. · Hepatology · 2018 Match 55

ActiTest FibroTest HBV

Prise en charge des personnes infectées par les virus de l’hépatite B ou de l’hépatite C — Rapport de recommandations 2014 Key publication

Match 53

FibroTest HBV HCV